|
Biogen Idec to Acquire Full Rights and Control of TYSABRI® from Elan for …
The Herald | HeraldOnline.com … (interferon beta-1a), TYSABRI and RITUXAN® (rituximab), the importance of TYSABRI’s sales growth, uncertainty of success in commercializing and developing other products, product competition, the occurrence of adverse safety events with our … |
Excess sugar bad for heart – Times of India
Times of IndiaExcess sugar bad for heartTimes of IndiaSucrose a type of sugar found in sweetened beverage, has been shown to cause type 2 diabetes in fruit flies which leads to heart malfunctions, said the study by scientists at the Sanford-Burnham Med…
Research Validates New Biomarkers For Risk Assessment Of Acute Kidney Injury – PR Newswire (press release)
MedPage TodayResearch Validates New Biomarkers For Risk Assessment Of Acute Kidney InjuryPR Newswire (press release)6, 2013 /PRNewswire-USNewswire/ — Two biomarkers used in combination can improve risk assessment of acute kidney injury (AKI), accordin…
Omega 3 fatty acids can protect against 'fatty' liver – India.Com Health
|
Omega 3 fatty acids can protect against ‘fatty’ liver
India.Com Health An omega-3 fatty acid counteracts the effect of non-alcoholic fatty liver disease (NAFLD), afflicting 75 percent of the obese, says a new study. The American Liver Foundation estimates that about 25 percent of the US population and 75 percent of the … |
New Zealand takes significant step towards national hospital medicines list – The Pharma Letter
New Zealand takes significant step towards national hospital medicines listThe Pharma LetterOne of the changes has been the addition of rituximab (MabThera, from Roche) to the rheumatology list. Rituximab, a targeted biologic medicine, had already been…
High-dose Vorinostat effective at treating relapsed lymphomas – HealthCanal.com
High-dose Vorinostat effective at treating relapsed lymphomasHealthCanal.comPreclinical studies at Fred Hutch and other research centers have found Vorinostat to be effective when used along with the standard chemotherapy combo, which is known by the a…
Omega-3 fatty acids fight liver disease in obese – Times of India
Times of IndiaOmega-3 fatty acids fight liver disease in obeseTimes of IndiaAn omega-3 fatty acid counteracts the effect of non-alcoholic fatty liver disease (NAFLD), afflicting 75 per cent of the obese, says a new study. The American Liver Foundation …
Organ donor plan brings fresh hope – Belfast Telegraph
 Belfast Newsletter |
Organ donor plan brings fresh hope
Belfast Telegraph Human nature being what it is, many people mean to join the organ donor register but never get round to it. That problem would not exist under the proposed system and experience elsewhere in Europe shows a much higher percentage of people on the … NI leaders back organ donation reformU.TV Calls For ‘Opt Out’ Organ Donor Debate4ni.co.uk Organ donation opt-out plan for NIBelfast Newsletter Irish Times –Irish Independent –Nursing Times all 15 news articles » |
'Omega-3 fatty acids act against liver disease in obese' – Newstrack India
|
‘Omega-3 fatty acids act against liver disease in obese’
Newstrack India Washington, Feb 6 (IANS) An omega-3 fatty acid counteracts the effect of non-alcoholic fatty liver disease (NAFLD), afflicting 75 percent of the obese, says a new study. The American Liver Foundation estimates that about 25 percent of the US population … |
Fake TB drugs swamp Third world countries – Daily Monitor
Fake TB drugs swamp Third world countriesDaily MonitorOut of 713 samples, 9.1 percent failed these basic quality control tests, according to the probe, published in the International Journal of Tuberculosis and Lung Disease. SHARE THIS STORY. Tweet. Af…